Akebia Therapeutics, Inc.

Rachunek Zysków i Strat


index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41
Rok finansowy 2014 2015 2015 2015 2015 2016 2016 2016 2016 2017 2017 2017 2017 2018 2018 2018 2018 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025
Kwartał Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1
Data 2014-12-31 2015-03-31 2015-06-30 2015-09-30 2015-12-31 2016-03-31 2016-06-30 2016-09-30 2016-12-31 2017-03-31 2017-06-30 2017-09-30 2017-12-31 2018-03-31 2018-06-30 2018-09-30 2018-12-31 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 0 0 0 0 0 0 0 0 2 21 29 41 87 46 49 53 60 73 101 92 70 88 90 60 57 52 53 49 60 62 127 49 55 40 56 42 56 33 44 37 46 57
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% inf% inf% inf% 5588.3% 120.1% 71.1% 28.8% -31.46% 58.2% 106.6% 73.0% 16.2% 21.8% -10.58% -34.78% -18.48% -40.88% -41.30% -18.72% 5.1% 18.0% 139.6% 0.4% -7.42% -34.96% -55.53% -14.13% 1.8% -18.74% -22.58% -10.98% -17.26% 75.8%
Marża brutto 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% -2078.18% -187.80% -53.40% -42.22% 21.7% -33.69% -47.39% -32.85% 87.2% 57.0% 62.6% 58.4% 45.2% 68.7% -93.71% 49.4% -11.53% 33.8% 0.8% 67.3% 15.5% 49.2% 85.3% 22.5% 96.3% 51.4% 69.3% 57.2% 66.1% 63.3% 60.0% 62.2% 56.2% 86.7%
Koszty i Wydatki (mln) 11 11 11 20 20 26 36 36 40 66 51 65 76 70 84 81 150 149 160 148 164 148 264 118 142 117 132 104 126 120 78 97 60 65 65 55 55 47 52 50 61 43
EBIT (mln) -11 -11 -11 -20 -20 -26 -36 -36 -38 -45 -22 -24 11 -24 -36 -28 -90 -76 -60 -56 -95 -59 -174 -58 -85 -65 -79 -55 -66 -58 49 -48 -5 -25 -9 -13 1 -15 -9 -13 -14 14
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 89.0% 139.0% 232.3% 83.9% 89.7% 72.7% -38.83% -33.18% 129.9% -45.53% 61.1% 15.2% -892.96% 210.1% 66.9% 100.8% 5.3% -22.17% 192.0% 3.9% -10.00% 9.8% -54.35% -5.52% -22.54% -9.92% 161.6% -12.56% -92.25% -57.55% -118.42% -72.84% 126.8% -40.09% -3.01% -4.07% -1141.27% 190.8%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2478.44% -215.54% -77.62% -58.56% 13.0% -53.34% -73.09% -52.37% -150.60% -104.55% -59.05% -60.78% -136.43% -66.82% -192.83% -96.84% -150.63% -124.15% -149.95% -112.57% -110.99% -94.80% 38.5% -98.02% -9.30% -61.88% -15.96% -31.00% 2.4% -45.63% -19.99% -33.41% -30.77% 23.6%
Przychody fiansowe (mln) 0 0 0 0 0 0 0 0 0 0 1 1 1 1 2 2 2 1 0 0 0 0 0 0 2 0 0 0 0 0 0 4 2 2 2 0 0 0 0 0 0 0
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 1 1 1 1 2 2 2 1 0 0 0 2 2 2 2 5 5 5 5 5 5 4 2 2 2 1 1 2 2 7 7 -8
Amortyzacja (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 10 10 10 10 10 10 7 8 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 0
EBITDA (mln) -10 -11 -11 -20 -20 -26 -36 -36 -38 -45 -22 -24 12 -24 -35 -28 -87 -66 -49 -46 -87 -49 -164 -51 -77 -56 -69 -45 -57 -48 43 -41 -1 -16 -0 -4 12 -6 3 -4 -7 14
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2470.36% -214.89% -77.20% -58.16% 13.2% -52.90% -72.65% -51.94% -150.60% -104.55% -49.44% -60.78% -136.43% -55.55% -182.15% -85.13% -150.63% -105.63% -129.58% -92.25% -110.99% -77.69% 46.0% -76.39% -7.08% -61.62% -15.36% -8.33% 19.2% -16.88% 1.6% -10.70% -14.16% 23.6%
NOPLAT (mln) -10 -11 -11 -19 -20 -26 -36 -36 -38 -45 -22 -23 12 -23 -34 -26 -88 -75 -59 -56 -96 -61 -176 -60 -87 -70 -83 -60 -71 -62 29 -52 -8 -26 -11 -14 1 -18 -9 -20 -23 6
Podatek (mln) -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -1 -1 0 -1 -2 -2 -28 -3 -1 -1 -2 2 2 3 -8 5 6 6 -5 4 5 4 1 -9 0 1 -0 9 0 0 0 0
Zysk Netto (mln) -10 -11 -11 -19 -20 -26 -36 -36 -38 -45 -22 -23 12 -23 -34 -26 -88 -72 -58 -55 -94 -61 -176 -60 -87 -70 -83 -60 -71 -66 29 -56 -9 -17 -11 -14 1 -18 -9 -20 -23 6
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 91.5% 141.2% 234.7% 86.4% 90.7% 72.7% -39.86% -36.28% 132.4% -47.43% 58.3% 12.6% -819.63% 209.3% 70.7% 109.6% 6.9% -16.12% 202.1% 9.8% -7.92% 14.5% -52.75% -0.69% -18.76% -4.64% 135.3% -6.40% -87.61% -74.77% -138.16% -74.00% 107.0% 7.5% -23.18% 38.3% -3814.01% 134.0%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2466.58% -213.48% -75.45% -56.04% 14.1% -50.99% -69.82% -48.99% -147.65% -99.66% -57.71% -59.35% -135.84% -68.66% -194.97% -99.95% -153.44% -133.03% -156.93% -122.13% -118.58% -107.54% 23.1% -113.83% -15.87% -41.71% -19.82% -34.46% 1.1% -55.16% -19.66% -53.54% -49.04% 10.7%
EPS -0.52 -0.53 -0.4 -0.68 -0.54 -0.7 -0.95 -0.96 -0.99 -1.15 -0.53 -0.49 0.25 -0.48 -0.6 -0.46 -0.76 -0.62 -0.49 -0.46 -0.79 -0.47 -1.28 -0.42 -0.6 -0.45 -0.51 -0.34 -0.4 -0.37 0.16 -0.3 -0.0476 -0.0906 -0.0598 -0.0769 0.0032 -0.0878 -0.0409 -0.0953 -0.11 0.03
EPS (rozwodnione) -0.52 -0.53 -0.4 -0.68 -0.54 -0.7 -0.95 -0.96 -0.98 -1.15 -0.53 -0.49 0.25 -0.48 -0.6 -0.46 -0.76 -0.62 -0.49 -0.46 -0.79 -0.47 -1.28 -0.42 -0.6 -0.45 -0.51 -0.34 -0.4 -0.37 0.15 -0.3 -0.0476 -0.0906 -0.0598 -0.0769 0.0032 -0.0878 -0.0409 -0.0953 -0.11 0.03
Ilośc akcji (mln) 20 20 27 29 37 37 38 38 38 39 41 47 47 49 57 57 117 117 118 119 119 128 137 143 145 154 161 174 175 180 184 184 184 185 187 188 190 205 210 210 211 235
Ważona ilośc akcji (mln) 20 20 27 29 37 37 38 38 39 39 41 47 49 49 57 57 117 117 118 119 119 128 137 143 145 154 161 174 176 180 190 184 184 185 187 188 190 205 210 210 211 242
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD